Drug interactions between tacrolimus and phenytoin in Japanese heart transplant recipients: 2 case reports

International Journal of Clinical Pharmacology and Therapeutics

Volumn 45, Issue 9, 2007, Pages 524-528

  Wada, K ^a   Takada, M ^b   Ueda, T ^c   Ochi, H ^a   Kotake, T ^a   Morishita, H ^a   Hanatani, A ^a   Nakatani, T ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b KINKI UNIVERSITY   (Japan)

^c KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Drug interactions; Japanese heart transplant recipients; Phenytoin; Tacrolimus

Indexed keywords

CYCLOSPORIN; CYTOCHROME P450 3A4; ETIRACETAM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHENYTOIN; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; CONGESTIVE CARDIOMYOPATHY; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JAPANESE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; SEIZURE; VISUAL FIELD;

EID: 34548621154     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP45524     Document Type: Article

References (10)

1. Anderson GD. A mechanistic approach to antiepileptic drug interactions. Ann Pharmacother. 1998; 32: 554-563.
2. Fireman M, DiMartini AF, Armstrong SC, Cozza KL. Immunosuppressants. Psychosomatics. 2004; 45: 354-360.
3. Formea CM, Evans CG, Karlix JL. Altered cytochrome P450 metabolism of calcineurin inhibitors: case report and review of the literature. Pharmacotherapy. 2005; 25: 1021-1029.
4. Karasu Z, Gurakar A, Carlson J, Pennington S, Kerwin B, Wright H, Nour B, Sebastian A. Acute tacrolimus overdose and treatment with phenytom in liver transplant recipients. J Oklahoma State Med Assoc. 2001; 94: 121-123.
5. Keown PA, Laupacis A, Carruthers G, Stawecki M, Koegler J, McKenzie FN, Wall W, Stiller CR. Interaction between phenytoin and cyclosporine following organ transplantation. Transplantation 1984; 38: 304-306.
6. Kino T, Hatanaka H, Miyata S, Inamura N, Nishiyama M, Yajima T, Goto T, Okuhara M, Kohsaka M, Aoki H et al. FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot. 1987; 40: 1256-1265.
7. Lamba JK, Lin YS, Schuetz EG, Thummel KE. Genetic contribution to variable human CYP3A-mediated metabolism. Adv Drug Deliv Rev. 2002; 54: 1271-1294.
8. Michalets EL. Update: clinically significant cytochrome P-450 drug interactions. Pharmacotherapy. 1998; 18: 84-112.
9. Moreno M, Latorre A, Manzanares C, Morales E, Herrero JC, Dominguez-Gil B, Carreno A, Cubas A, Delgado M, Andres A, Morales JM. Clinical management of tacrolimus drug interactions in renal transplant patients. Transplant Proc. 1999; 31: 2252-2253.
10. Ochiai T, Nakajima K, Nagata M, Hori S, Asano T, Isono K. Studies of the induction and maintenance of long-term graft acceptance by treatment with FK 506 in heterotopic cardiac allotransplantation in rats. Transplantation. 1987; 44: 734-738.